Unknown

Dataset Information

Novel Approaches for Immunosuppression in Graves' Hyperthyroidism and Associated Orbitopathy.


ABSTRACT:

Background

Both Graves' hyperthyroidism (GH) and Graves' orbitopathy (GO) are associated with significant adverse health consequences. All conventional treatment options have limitations regarding efficacy and safety. Most importantly, they do not specifically address the underlying immunological mechanisms. We aim to review the latest development of treatment approaches in these two closely related disorders.

Summary

Immunotherapies of GH have recently demonstrated clinical efficacy in preliminary studies. They include ATX-GD-59, an antigen-specific immunotherapy which restores immune tolerance to the thyrotropin receptor; iscalimab, an anti-CD40 monoclonal antibody which blocks the CD40-CD154 costimulatory pathway in B-T cell interaction; and K1-70, a thyrotropin receptor-

SUBMITTER: Lee ACH 

PROVIDER: S-EPMC7802437 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature